Familial Hypertriglyceridemia Treatments

Find Familial Hypertriglyceridemia Treatments

Generic Name

Atorvastatin

Brand Names
Amlodipine, Amlodipine Besylate, Atorvaliq, Azor, Benazepril, Benicar, Caduet, Katerzia, Lipitor, Lotensin, Lotrel, Norliqva, Norvasc, Olmesartan Medoxomil, Olmesartan Medoxomil Amlodipine, Sdamlo, Tribenzor
FDA approval date: June 21, 1991
Classification: Calcium Channel Blocker
Form: Tablet, Suspension, Capsule, Solution

What is Amlodipine (Atorvastatin)?

Amlodipine and benazepril hydrochloride capsules are a combination capsule of amlodipine, a dihydropyridine calcium channel blocker and benazepril, an angiotensin-converting enzyme inhibitor. Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Phase II Interventional Study Using Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Background: Cisplatin is used to treat head and neck cancer. People who take this drug are at risk for hearing loss. Atorvastatin is a drug used to treat high cholesterol. It might reduce the risk of cisplatin-induced hearing loss.

PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)

Summary: PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the benefit of statins for reducing the primary composite of death, dementia, and persistent disability a...

Clinical Study of CD123 Targeting Chimeric Antigen Receptor NK Cells (CAR-NK) in the Treatment of Relapse/Refractory Acute Myeloid Leukemia (AML)or Blastic Plasmacytoid Dendritic Cell Neoplasm(BPDCN)

Summary: This is a clincal trial initiated by investigator to evaluate the safety and efficacy of anti-CD123 CAR-NK in the treatment of patients with relapsed/refractory acute myeloid leukemia or blastic plasma cell like dendritic cell tumors.

Brand Information

    Amlodipine and Benazepril Hydrochloride (Amlodipine and Benazepril Hydrochloride)
    WARNING: FETAL TOXICITY
    When pregnancy is detected, discontinue amlodipine and benazepril hydrochloride as soon as possible
    1DOSAGE FORMS AND STRENGTHS
    Amlodipine and benazepril hydrochloride capsules USP are available as follows:
    2CONTRAINDICATIONS
    • Do not coadminister aliskiren with angiotensin receptor blockers (ARBs), angiotensin-converting enzyme (ACE) inhibitors, including amlodipine and benazepril hydrochloride capsules in patients with diabetes.
    • Amlodipine and benazepril hydrochloride capsules  are contraindicated in patients with a history of angioedema, with or without previous ACE inhibitor treatment, or patients who are hypersensitive to benazepril, to any other ACE inhibitor, to amlodipine, or to any of the excipients of amlodipine and benazepril hydrochloride capsules.
    • Amlodipine and benazepril hydrochloride capsules are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer amlodipine and benazepril hydrochloride capsules within 36 hours of switching to or from a neprilysin inhibitor, e.g., sacubitril/valsartan
    3OVERDOSAGE
    Only a few cases of human overdose with amlodipine have been reported. One patient was asymptomatic after a 250 mg ingestion; another, who combined 70 mg of amlodipine with an unknown large quantity of a benzodiazepine, developed refractory shock and died.
    4DESCRIPTION
    Amlodipine and benazepril hydrochloride capsules USP are a combination of amlodipine besylate and benazepril hydrochloride.
    Benazepril hydrochloride USP is a white to off-white, crystalline powder, soluble (greater than 100 mg/mL) in water, in ethanol, and in methanol. Benazepril hydrochloride’s chemical name is 3-[[1-(ethoxycarbonyl)-3-phenyl-(1S)-propyl]amino]-2,3,4,5-tetrahydro-2-oxo-1
    Its molecular formula is C
    Benazeprilat, the active metabolite of benazepril, is a nonsulfhydryl ACE inhibitor. Benazepril is converted to benazeprilat by hepatic cleavage of the ester group.
    Amlodipine besylate USP is a white or almost white powder, slightly soluble in water and sparingly soluble in ethanol. Its chemical name is (R,S)3-ethyl-5-methyl-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4­-dihydro-6-methyl-3,5-pyridinedicarboxylate benzenesulfonate; its structural formula is:
    Its molecular formula is C
    Amlodipine besylate is the besylate salt of amlodipine, a dihydropyridine calcium channel blocker.
    5CLINICAL STUDIES
    Over 950 patients received amlodipine and benazepril hydrochloride once-daily in 6 double-blind, placebo-controlled studies. The antihypertensive effect of a single dose persisted for 24 hours, with peak reductions achieved 2 to 8 hours after dosing.
    6HOW SUPPLIED/STORAGE AND HANDLING
    Amlodipine and benazepril hydrochloride is available as capsules containing amlodipine besylate USP (13.9 mg, equivalent to 10 mg of amlodipine respectively), with 20 mg of benazepril hydrochloride USP providing for the following available combinations:  10 mg/20 mg. They are available as follows:
    7PATIENT COUNSELING INFORMATION
    Advise the patient to read the FDA-approved patient labeling (
    Pregnancy:Advise female patients of childbearing age about the consequences of exposure to amlodipine and benazepril hydrochloride during pregnancy. Discuss treatment options with women planning to become pregnant. Ask patients to report pregnancies to their physicians as soon as possible [see 
    Symptomatic Hypotension:Advise patients that lightheadedness can occur, especially during the first days of therapy, and that it should be reported to their healthcare provider. Tell patients that if syncope occurs to discontinue amlodipine and benazepril hydrochloride capsules until the physician has been consulted. Caution all patients that inadequate fluid intake, excessive perspiration, diarrhea, or vomiting can lead to an excessive fall in blood pressure, with the same consequences of lightheadedness and possible syncope [see .
    Hyperkalemia:Advise patients not to use salt substitutes without consulting their healthcare provider [see .

    Distributed by:
    Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road
    East Windsor, NJ 08520

    Manufactured by:
    Aurobindo Pharma Limited Hyderabad-500 032, India

    Revised: 11/2021
    8Patient Information
    Amlodipine and Benazepril Hydrochloride Capsules USP Read this Patient Information leaflet before you start taking amlodipine and benazepril hydrochloride capsules and each time you get a refill. There may be new information. This leaflet does not replace talking with your doctor. If you have any questions, ask your doctor or pharmacist.
    9PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg/20 mg
    Rx only
    Amlodipine and
    10 mg*/20 mg


    72789412 LABEL